Executive Summary

Oct 2019
PROSPECTS
OTC dermatologicals still growing despite competition from Rx and dermocosmetic products

Sales of dermatologicals continued to increase in 2019, thanks to the growing levels of self-medication. There were advertising and promotional campaigns running in the 2017-2019 period for topical and even vaginal antifungals, benefiting sales of both OTC and Rx products, with the main emphasis being on the treatment of bacterial issues rather than fungi.

Increasing popularity of natural products

One of the main growth drivers is the switch towards more natural products at the expense of dermatologicals with potentially noxious ingredients – for instance corticoid-based creams. In nappy (diaper) rash treatments and paediatric dermatologicals, this can be seen in the recent “liniment” trend, with oleo-limestone liniment a popular choice.

Haemorrhoid treatments and antipruritics the most dynamic product areas

The most dynamic products in 2019 were haemorrhoid treatments and antipruritics. Haemorrhoid treatments performed well on the back of a growing level of self-medication, with Johnson & Johnson’s Titanoréïne line the dominant brand in this category.

COMPETITIVE LANDSCAPE
Johnson & Johnson extends its lead over Laboratoires Pierre Fabre in 2019

Johnson & Johnson Santé Beauté France continued to lead what is an extremely fragmented competitive landscape in dermatologicals, followed by Laboratoires Pierre Fabre. Both players cover many types of dermatologicals with a large number of brands and products.

Strong competition in antiparasitics/lice (head and body) treatments

Antiparasitics/lice (head and body) treatments is led by Coopération Pharmaceutique Française SAS (Cooper) with its Pouxit brand, followed by Omega Pharma with Paranix and Merck Médication Familiale with its Poux Apaisyl range. However, there is not only strong competition between these players, but also with other companies operating in the category.

Cicatryl benefits from advertising support in topical germicidals/antiseptics

Good performances in topical germicidals/antiseptics can be attributed to OTC repurchases of Rx products and advertising of OTC products. Bayer’s Biseptine recorded growth in 2019 thanks to OTC repurchases in the summer by consumers who had previously used the product on reimbursed prescription.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in France

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in France with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in France, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in France market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in France?
  • What are the major brands in France?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in France - Category analysis

HEADLINES

PROSPECTS

OTC dermatologicals still growing despite competition from Rx and dermocosmetic products
Increasing popularity of natural products
Haemorrhoid treatments and antipruritics the most dynamic product areas

COMPETITIVE LANDSCAPE

Johnson & Johnson extends its lead over Laboratoires Pierre Fabre in 2019
Strong competition in antiparasitics/lice (head and body) treatments
Cicatryl benefits from advertising support in topical germicidals/antiseptics

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in France - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to grow despite declining self-medication levels
Reverse switches and trend towards more natural products
Sanofi continues to lead
Chemists/pharmacies continues to dominate distribution
Continued current value growth expected over the forecast period

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format: % Value 2014-2019
Table 16 Distribution of Consumer Health by Format and Category: % Value 2019
Table 17 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2018-2019

DEFINITIONS

SOURCES

Summary 2 Research Sources